Anhui Huangshan Capsule Co Ltd (002817) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anhui Huangshan Capsule Co Ltd (002817) has a cash flow conversion efficiency ratio of 0.046x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.15 Million ≈ $6.61 Million USD) by net assets (CN¥973.03 Million ≈ $142.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002817 equity to assets ratio to measure how much of total assets are equity-financed.
Anhui Huangshan Capsule Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Anhui Huangshan Capsule Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Anhui Huangshan Capsule Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Anhui Huangshan Capsule Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Huangshan Capsule Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zona Franca de Iquique S.A
SN:ZOFRI
|
0.072x |
|
Launch One Acquisition Corp. Unit
NASDAQ:LPAAU
|
0.000x |
|
Launch Two Acquisition Corp. Class A Ordinary Shares
NASDAQ:LPBB
|
-0.001x |
|
Strike Energy Ltd
AU:STX
|
0.079x |
|
Thoresen Thai Agencies Public Company Limited
BK:TTA-R
|
0.014x |
|
Formosan Rubber Group Inc
TW:2107
|
0.014x |
|
IAR Systems Group AB (publ)
ST:IAR-B
|
0.096x |
|
Al Aqar Healthcare Reit
KLSE:5116
|
0.102x |
Annual Cash Flow Conversion Efficiency for Anhui Huangshan Capsule Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Anhui Huangshan Capsule Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 002817 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥973.03 Million ≈ $142.38 Million |
CN¥107.44 Million ≈ $15.72 Million |
0.110x | +59.56% |
| 2024-12-31 | CN¥917.76 Million ≈ $134.30 Million |
CN¥63.51 Million ≈ $9.29 Million |
0.069x | -37.55% |
| 2023-12-31 | CN¥901.11 Million ≈ $131.86 Million |
CN¥99.86 Million ≈ $14.61 Million |
0.111x | +14.02% |
| 2022-12-31 | CN¥854.21 Million ≈ $125.00 Million |
CN¥83.02 Million ≈ $12.15 Million |
0.097x | -8.56% |
| 2021-12-31 | CN¥809.98 Million ≈ $118.52 Million |
CN¥86.09 Million ≈ $12.60 Million |
0.106x | +29.68% |
| 2020-12-31 | CN¥765.15 Million ≈ $111.97 Million |
CN¥62.71 Million ≈ $9.18 Million |
0.082x | +14.42% |
| 2019-12-31 | CN¥726.33 Million ≈ $106.28 Million |
CN¥52.03 Million ≈ $7.61 Million |
0.072x | +81.29% |
| 2018-12-31 | CN¥696.59 Million ≈ $101.93 Million |
CN¥27.52 Million ≈ $4.03 Million |
0.040x | -40.75% |
| 2017-12-31 | CN¥666.10 Million ≈ $97.47 Million |
CN¥44.42 Million ≈ $6.50 Million |
0.067x | +29.37% |
| 2016-12-31 | CN¥630.95 Million ≈ $92.33 Million |
CN¥32.53 Million ≈ $4.76 Million |
0.052x | -58.59% |
| 2015-12-31 | CN¥323.92 Million ≈ $47.40 Million |
CN¥40.32 Million ≈ $5.90 Million |
0.124x | -33.35% |
| 2014-12-31 | CN¥278.78 Million ≈ $40.79 Million |
CN¥52.07 Million ≈ $7.62 Million |
0.187x | +91.21% |
| 2013-12-31 | CN¥236.77 Million ≈ $34.65 Million |
CN¥23.13 Million ≈ $3.38 Million |
0.098x | -70.66% |
| 2012-12-31 | CN¥197.36 Million ≈ $28.88 Million |
CN¥65.70 Million ≈ $9.61 Million |
0.333x | +116.86% |
| 2011-12-31 | CN¥149.43 Million ≈ $21.87 Million |
CN¥22.94 Million ≈ $3.36 Million |
0.153x | -- |
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more